Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT04299542

NCT04299542
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have one or more spots or areas of concern in your lung (solid or part-solid) that are 1 centimetre or larger in size

Who may not be able to join:

  • You are under 18 years old
  • You are not able to give your own consent to take part in the study
  • You are unable to stay still or hold your breath long enough for a safe biopsy procedure
  • The lung spot or area being looked at is smaller than 1 centimetre
  • The lung spot or area is located too close (within 1 centimetre) to important structures in the chest, such as major blood vessels or the central chest area
  • The lung spot or area is located near the outer part of the lung and could safely be reached using an ultrasound-guided biopsy instead

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Chinese University of Hong Kong
Registry
clinicaltrials_gov
Start date
4 May 2020
Est. completion
22 November 2021

Where this trial is recruiting

Hong Kong

Primary endpoints

The number of needle repositioning to reach the target

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov